Difficulty: Medium
Average Score: 89%
Practice
Intravenous verapamil:
Correct answer
A
Rationale
Intravenous verapamil is a calcium channel blocker used for various cardiovascular conditions. The correct answer is A) May terminate supraventricular tachycardia. Verapamil is effective in terminating supraventricular tachycardias by slowing conduction through the AV node. It is a first-line agent for acute termination of supraventricular tachycardias.
Option B) Must not be given to patients receiving beta blockers is incorrect. Verapamil can be safely used in patients receiving beta blockers but caution is advised due to the risk of additive negative effects on heart rate and contractility.
Option C) Reduces digoxin excretion is incorrect. Verapamil can increase digoxin levels by inhibiting its excretion, leading to potential toxicity. Monitoring of digoxin levels is necessary when verapamil is co-administered.
Option D) One must delay DC cardioversion at least 2 hours after a dose is incorrect. There is no specific requirement to delay cardioversion after verapamil administration. However, caution should be exercised when using verapamil in patients who may require cardioversion due to its effects on cardiac conduction.
Educational context: Understanding the pharmacological properties of intravenous verapamil is crucial for healthcare professionals managing cardiovascular emergencies. Knowledge of its indications, contraindications, and potential drug interactions is essential for safe and effective patient care. This information ensures proper medication administration and monitoring to achieve optimal patient outcomes.
Option B) Must not be given to patients receiving beta blockers is incorrect. Verapamil can be safely used in patients receiving beta blockers but caution is advised due to the risk of additive negative effects on heart rate and contractility.
Option C) Reduces digoxin excretion is incorrect. Verapamil can increase digoxin levels by inhibiting its excretion, leading to potential toxicity. Monitoring of digoxin levels is necessary when verapamil is co-administered.
Option D) One must delay DC cardioversion at least 2 hours after a dose is incorrect. There is no specific requirement to delay cardioversion after verapamil administration. However, caution should be exercised when using verapamil in patients who may require cardioversion due to its effects on cardiac conduction.
Educational context: Understanding the pharmacological properties of intravenous verapamil is crucial for healthcare professionals managing cardiovascular emergencies. Knowledge of its indications, contraindications, and potential drug interactions is essential for safe and effective patient care. This information ensures proper medication administration and monitoring to achieve optimal patient outcomes.